Other Events ·
On June 11, 2026, OraSure Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) cleared the…
OSUROrasure Technologies Inc
On June 11, 2026, OraSure Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) cleared the Colli-Pee Dx Urine Collection Kit from its subsidiary DNA Genotek Inc. The kit is designed for use with Roche Molecular Systems, Inc. tests for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium on Roche's cobas 5800, 6800, and 8800 molecular diagnostic systems. The FDA-cleared kit enables at-home self-collection of first-void urine for both male and female patients. OraSure Technologies is a medical diagnostics company that develops and rapid diagnostic tests.